Back to MW Marshall Wace, LLP
TNGX
Showing 8 of 13 quarters
Position history for MWMarshall Wace, LLP's holdings in Tango Therapeutics, Inc.
Yes. Marshall Wace holds 174,909 shares of TNGX (Tango Therapeutics), worth $5.5M, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$5.5M
Current Shares
174,909
Total Value Change
+$4.9M
Total Shares Change
+101,787
Quarter-by-Quarter History